EUVIMEDEUVIMED entdecken
Crossref

Plant-Derived and Semi-Synthetic Calanolide Compounds with in Vitro Activity against Both Human Immunodeficiency Virus Type 1 and Human Cytomegalovirus

Z Q Xu, E R Kern, L Westbrook, L B Allen, R W Buckheit, C K Tseng, T Jenta, M T Flavin

Antiviral Chemistry and Chemotherapy · 2000

DOI: 10.1177/095632020001100102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antiviral Chemistry and Chemotherapy, 2000. Verfasst von Z Q Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: MediChem Research and Sarawak MediChem Pharmaceuticals, Lemont, IL 60439, USA. zxu@mcr.medichem.com. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plant-derived and semi-synthetic calanolide compounds with anti-human immunodeficiency virus type 1 (HIV-1) activity were tested for anti-human cytomegalovirus (HCMV) activity in both cytopathic effect inhibition and plaque reduction assays. The results indicated that the anti-HCMV activity of calanolide compounds does not correlate with their activity against HIV-1. The semi-synthetic 12-keto derivatives tended to be more active against HCMV than the corresponding 12-OH congeners, which were more active against HIV-1. It appeared that the 7,8-unsaturated double bond in the chromene ring played a certain role in maintaining activities against both HCMV and HIV-1. Saturation of the double bond increased the EC 50 values against both viruses, with concomitant increase in toxicity. The calanolide compounds reported here are the first non-nucleoside analogues capable of inhibiting both HIV-1 and HCMV and, therefore, may be useful chemoprophylactic agents for HCMV in HIV-infected people or vice versa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-HIV AgentsCells, CulturedCoumarinsCytomegalovirusCytopathogenic Effect, ViralHIV-1HumansMicrobial Sensitivity TestsPyranocoumarinsViral Plaque Assay

Substanzen

Anti-HIV AgentsCoumarinsPyranocoumarinscalanolide A

Autor:innen und Institutionen

  • MediChem Research and Sarawak MediChem Pharmaceuticals, Lemont, IL 60439, USA. zxu@mcr.medichem.com

Förderung

  • NIAID NIH HHS

Zitieren

APA

Xu, Z. Q., Kern, E. R., Westbrook, L., Allen, L. B., Buckheit, R. W., Tseng, C. K., Jenta, T., & Flavin, M. T. (2000). Plant-Derived and Semi-Synthetic Calanolide Compounds with in Vitro Activity against Both Human Immunodeficiency Virus Type 1 and Human Cytomegalovirus. Antiviral Chemistry and Chemotherapy. https://doi.org/10.1177/095632020001100102

Vancouver

Xu ZQ, Kern ER, Westbrook L, Allen LB, Buckheit RW, Tseng CK, et al. Plant-Derived and Semi-Synthetic Calanolide Compounds with in Vitro Activity against Both Human Immunodeficiency Virus Type 1 and Human Cytomegalovirus. Antiviral Chemistry and Chemotherapy. 2000. doi:10.1177/095632020001100102

BibTeX
@article{Xu2000,
  author = {Xu, Z Q and Kern, E R and Westbrook, L and Allen, L B and Buckheit, R W and Tseng, C K and Jenta, T and Flavin, M T},
  title = {Plant-Derived and Semi-Synthetic Calanolide Compounds with in Vitro Activity against Both Human Immunodeficiency Virus Type 1 and Human Cytomegalovirus},
  journal = {Antiviral Chemistry and Chemotherapy},
  year = {2000},
  doi = {10.1177/095632020001100102}
}
Kostenlos starten →